FDA Drug Application (203560) for DEFERASIROX by ACTAVIS ELIZABETH

Back to FDA Applications sponsored by ACTAVIS ELIZABETH

Application Number203560
Product Number001
FormTABLET, FOR SUSPENSION;ORAL
Dosage125MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameDEFERASIROX
Active IngredientDEFERASIROX

Active IngredientCount
List of drugs with Active Ingredient DEFERASIROX3


Back to FDA Applications sponsored by ACTAVIS ELIZABETH